naltrexone

FDA Drug Profile — VIVITROL

naltrexone is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including VIVITROL. Available dosage forms: kit, injection, suspension.

Drug details

Generic Name
naltrexone
Brand Names
VIVITROL
Application Number
NDA021897
Sponsor
Alkermes, Inc.
NDC Codes
5
Dosage Forms
KIT, INJECTION, SUSPENSION
Active Ingredients
NALTREXONE

Indications and Usage

1 INDICATIONS AND USAGE Treatment with VIVITROL should be part of a comprehensive management program that includes psychosocial support. VIVITROL contains naltrexone, an opioid antagonist, and is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration ( 1.1 ). VIVITROL is indicated for the prevention of relapse to opioid dependence, following opioid detoxification ( 1.2 ). VIVITROL should be part of a comprehensive management program that includes psychosocial support ( 1 ). 1.1 Alcohol Dependence VIVITROL is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration. 1.2 Opioid Dependence VIVITROL is indicated for the prevention of relapse to opioid dependence, following opioid detoxification.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.